Open Prairie Ventures Leads NewLeaf Symbiotics’ Series A
Open Prairie Ventures has backed NewLeaf Symbiotics, an agricultural biotech firm. The investment, from Open Prairie Ventures II, was part of a $7.0 million Series A round of financing that will be used to further NewLeaf Symbiotics’ field trials. Other investors in the syndicate include Rockport Capital, Pangaea Ventures and several individuals.
15 January 2013•3 mins read
